GEORGE HUTTON to Alemtuzumab
This is a "connection" page, showing publications GEORGE HUTTON has written about Alemtuzumab.
Connection Strength
0.187
-
Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 years. Mult Scler Relat Disord. 2020 Aug; 43:102146.
Score: 0.170
-
Human herpesvirus-6 encephalitis following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2007 Jun; 39(11):705-9.
Score: 0.017